Results 111 to 120 of about 2,044 (190)

Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction. [PDF]

Nat Cardiovasc Res
Aggarwal R, Bhatt DL, Hernandez AF, Anker SD, Harrington J, Jones WS, Mattheus M, Petrie MC, Steubl D, Sumin M, Thanam V, Udell JA, Butler J.   +12 more
europepmc   +1 more source

Supporting Community-Based Watershed Efforts [PDF]

, 2011
Lewicki, Christine
core   +1 more source

Incidence, management and outcomes of patients with acute chest pain presenting to the emergency departments in China: findings from a prospective multicentre registry. [PDF]

BMJ Open
Cheng K, Zheng W, Wang J, Wu S, Zheng J, Sang W, Ma J, Pang J, Pan C, Wang G, Wu Y, Chen Y, Xu F.   +12 more
europepmc   +1 more source

15-Year trends, predictors, and outcomes of heart failure hospitalization complicating first acute myocardial infarction in the modern percutaneous coronary intervention era. [PDF]

Eur Heart J Open
Rashid M, Abramov D, Naseer MU, Van Spall HGC, Ahmed FZ, Lawson C, Dafaalla M, Kontopantelis E, Mohamed MO, Petrie MC, Mamas MA.   +10 more
europepmc   +1 more source

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled. [PDF]

JACC Adv
Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Pfarr E, Gasior T, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, Verma S, EMPEROR-Pooled Trial Committees and Investigators.   +13 more
europepmc   +1 more source

MRI for managing intermediate & low risk prostate cancer [PDF]

core   +1 more source

The impact of sodium–glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials [PDF]

Eri Kato, Koji Hasegawa, Koh Ono
openalex   +1 more source

International law enforcement, information exchange in an evolving data protection landscape [PDF]

, 2018
Vermeulen, Gert
core   +1 more source

Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Semirani-Nezhad D, Soleimani H, Taebi M, Roozbehi K, Jahangiri S, Sattartabar B, Takaloo F, Parastooei B, Asfa E, Salabat D, Alishahi MM, Mosayebi F, Jenab Y, Gupta R, Kuno T, Aronow W, Hosseini K.   +16 more
europepmc   +1 more source

Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin. [PDF]

Biomedicines
Cozma D, Văcărescu C, Stoicescu C.
europepmc   +1 more source